nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—DHFR—Methotrexate—psoriasis	0.149	0.195	CbGbCtD
Trimethoprim—TYMS—Methotrexate—psoriasis	0.104	0.136	CbGbCtD
Trimethoprim—CYP2C8—Tazarotene—psoriasis	0.0794	0.104	CbGbCtD
Trimethoprim—CYP2C8—Cholecalciferol—psoriasis	0.0339	0.0444	CbGbCtD
Trimethoprim—CYP2C8—Mycophenolate mofetil—psoriasis	0.0294	0.0385	CbGbCtD
Trimethoprim—CYP3A4—Calcitriol—psoriasis	0.0267	0.0349	CbGbCtD
Trimethoprim—CYP2C9—Cholecalciferol—psoriasis	0.0237	0.0309	CbGbCtD
Trimethoprim—CYP2C8—Hydrocortisone—psoriasis	0.0236	0.0309	CbGbCtD
Trimethoprim—CYP2C8—Cyclosporine—psoriasis	0.0223	0.0292	CbGbCtD
Trimethoprim—CYP3A4—Methoxsalen—psoriasis	0.0208	0.0272	CbGbCtD
Trimethoprim—ABCB1—Mycophenolate mofetil—psoriasis	0.0199	0.026	CbGbCtD
Trimethoprim—ABCB1—Betamethasone—psoriasis	0.0171	0.0223	CbGbCtD
Trimethoprim—ABCB1—Prednisolone—psoriasis	0.0168	0.022	CbGbCtD
Trimethoprim—ABCB1—Hydrocortisone—psoriasis	0.016	0.0209	CbGbCtD
Trimethoprim—ABCB1—Prednisone—psoriasis	0.0159	0.0208	CbGbCtD
Trimethoprim—CYP2C9—Cyclosporine—psoriasis	0.0155	0.0203	CbGbCtD
Trimethoprim—ABCB1—Cyclosporine—psoriasis	0.0151	0.0197	CbGbCtD
Trimethoprim—CYP2C8—Dexamethasone—psoriasis	0.0147	0.0192	CbGbCtD
Trimethoprim—CYP3A4—Cholecalciferol—psoriasis	0.0138	0.018	CbGbCtD
Trimethoprim—CYP3A4—Mycophenolate mofetil—psoriasis	0.0119	0.0156	CbGbCtD
Trimethoprim—CYP3A4—Triamcinolone—psoriasis	0.0119	0.0156	CbGbCtD
Trimethoprim—CYP2C9—Dexamethasone—psoriasis	0.0102	0.0134	CbGbCtD
Trimethoprim—CYP3A4—Betamethasone—psoriasis	0.0102	0.0134	CbGbCtD
Trimethoprim—CYP3A4—Prednisolone—psoriasis	0.0101	0.0132	CbGbCtD
Trimethoprim—ABCB1—Dexamethasone—psoriasis	0.00993	0.013	CbGbCtD
Trimethoprim—CYP3A4—Hydrocortisone—psoriasis	0.00957	0.0125	CbGbCtD
Trimethoprim—CYP3A4—Prednisone—psoriasis	0.00953	0.0125	CbGbCtD
Trimethoprim—CYP3A4—Cyclosporine—psoriasis	0.00904	0.0118	CbGbCtD
Trimethoprim—ABCB1—Methotrexate—psoriasis	0.00798	0.0104	CbGbCtD
Trimethoprim—CYP3A4—Dexamethasone—psoriasis	0.00595	0.00779	CbGbCtD
Trimethoprim—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00139	0.0703	CbGpPWpGaD
Trimethoprim—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00113	0.0572	CbGpPWpGaD
Trimethoprim—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.000863	0.0436	CbGpPWpGaD
Trimethoprim—DHFR—G1/S-Specific Transcription—PCNA—psoriasis	0.000823	0.0416	CbGpPWpGaD
Trimethoprim—TYMS—Vitamin A—Acitretin—psoriasis	0.000816	0.113	CbGdCrCtD
Trimethoprim—TYMS—G1/S-Specific Transcription—PCNA—psoriasis	0.000718	0.0363	CbGpPWpGaD
Trimethoprim—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000703	0.0355	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—IL22—psoriasis	0.000603	0.0305	CbGpPWpGaD
Trimethoprim—TYMS—Tretinoin—Acitretin—psoriasis	0.00057	0.0791	CbGdCrCtD
Trimethoprim—TYMS—Alitretinoin—Acitretin—psoriasis	0.00057	0.0791	CbGdCrCtD
Trimethoprim—TYMS—Isotretinoin—Acitretin—psoriasis	0.00057	0.0791	CbGdCrCtD
Trimethoprim—DHFR—E2F mediated regulation of DNA replication—PCNA—psoriasis	0.000484	0.0245	CbGpPWpGaD
Trimethoprim—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000463	0.0234	CbGpPWpGaD
Trimethoprim—TYMS—E2F mediated regulation of DNA replication—PCNA—psoriasis	0.000423	0.0213	CbGpPWpGaD
Trimethoprim—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000358	0.0181	CbGpPWpGaD
Trimethoprim—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000354	0.0179	CbGpPWpGaD
Trimethoprim—DHFR—Folate Metabolism—CAT—psoriasis	0.000323	0.0163	CbGpPWpGaD
Trimethoprim—DHFR—Folate Metabolism—IL4—psoriasis	0.000297	0.015	CbGpPWpGaD
Trimethoprim—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000292	0.0147	CbGpPWpGaD
Trimethoprim—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000291	0.0147	CbGpPWpGaD
Trimethoprim—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000288	0.0145	CbGpPWpGaD
Trimethoprim—DHFR—Folate Metabolism—CRP—psoriasis	0.000256	0.0129	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	0.000255	0.0129	CbGpPWpGaD
Trimethoprim—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.00025	0.0126	CbGpPWpGaD
Trimethoprim—TYMS—Nucleotide metabolism—CAT—psoriasis	0.000246	0.0124	CbGpPWpGaD
Trimethoprim—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000236	0.0119	CbGpPWpGaD
Trimethoprim—DHFR—Folate Metabolism—ICAM1—psoriasis	0.000236	0.0119	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.000223	0.0113	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—PCNA—psoriasis	0.000195	0.00983	CbGpPWpGaD
Trimethoprim—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000192	0.00971	CbGpPWpGaD
Trimethoprim—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00019	0.00959	CbGpPWpGaD
Trimethoprim—DHFR—G1/S Transition—PCNA—psoriasis	0.000186	0.0094	CbGpPWpGaD
Trimethoprim—DHFR—Folate Metabolism—IFNG—psoriasis	0.000179	0.00905	CbGpPWpGaD
Trimethoprim—DHFR—Fluoropyrimidine Activity—TP53—psoriasis	0.000178	0.00899	CbGpPWpGaD
Trimethoprim—TYMS—Triamcinolone—Clobetasol propionate—psoriasis	0.00017	0.0236	CbGdCrCtD
Trimethoprim—TYMS—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.000166	0.023	CbGdCrCtD
Trimethoprim—TYMS—G1/S Transition—PCNA—psoriasis	0.000162	0.0082	CbGpPWpGaD
Trimethoprim—Insomnia—Mycophenolate mofetil—psoriasis	0.00016	0.000766	CcSEcCtD
Trimethoprim—Dyspepsia—Cyclosporine—psoriasis	0.000159	0.000764	CcSEcCtD
Trimethoprim—Nausea—Hydroxyurea—psoriasis	0.000159	0.000761	CcSEcCtD
Trimethoprim—Pruritus—Mycophenolic acid—psoriasis	0.000158	0.000759	CcSEcCtD
Trimethoprim—Shock—Hydrocortisone—psoriasis	0.000158	0.000759	CcSEcCtD
Trimethoprim—Myalgia—Triamcinolone—psoriasis	0.000158	0.000758	CcSEcCtD
Trimethoprim—Nervous system disorder—Hydrocortisone—psoriasis	0.000158	0.000756	CcSEcCtD
Trimethoprim—Pneumonia—Methotrexate—psoriasis	0.000158	0.000756	CcSEcCtD
Trimethoprim—Eye disorder—Prednisone—psoriasis	0.000158	0.000755	CcSEcCtD
Trimethoprim—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000158	0.000755	CcSEcCtD
Trimethoprim—Decreased appetite—Cyclosporine—psoriasis	0.000157	0.000754	CcSEcCtD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—PCNA—psoriasis	0.000157	0.00792	CbGpPWpGaD
Trimethoprim—Infestation—Methotrexate—psoriasis	0.000157	0.000752	CcSEcCtD
Trimethoprim—Infestation NOS—Methotrexate—psoriasis	0.000157	0.000752	CcSEcCtD
Trimethoprim—TYMS—Diflorasone—Clobetasol propionate—psoriasis	0.000157	0.0218	CbGdCrCtD
Trimethoprim—Depression—Methotrexate—psoriasis	0.000156	0.00075	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000156	0.000749	CcSEcCtD
Trimethoprim—Skin disorder—Hydrocortisone—psoriasis	0.000156	0.000749	CcSEcCtD
Trimethoprim—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000156	0.00787	CbGpPWpGaD
Trimethoprim—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.000156	0.000746	CcSEcCtD
Trimethoprim—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000156	0.000745	CcSEcCtD
Trimethoprim—TYMS—Fluoropyrimidine Activity—TP53—psoriasis	0.000155	0.00785	CbGpPWpGaD
Trimethoprim—Constipation—Cyclosporine—psoriasis	0.000155	0.000742	CcSEcCtD
Trimethoprim—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000154	0.00779	CbGpPWpGaD
Trimethoprim—Renal failure—Methotrexate—psoriasis	0.000154	0.000739	CcSEcCtD
Trimethoprim—Angioedema—Betamethasone—psoriasis	0.000154	0.000738	CcSEcCtD
Trimethoprim—Angioedema—Dexamethasone—psoriasis	0.000154	0.000738	CcSEcCtD
Trimethoprim—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000154	0.00777	CbGpPWpGaD
Trimethoprim—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000154	0.000736	CcSEcCtD
Trimethoprim—Anorexia—Hydrocortisone—psoriasis	0.000153	0.000735	CcSEcCtD
Trimethoprim—Diarrhoea—Mycophenolic acid—psoriasis	0.000153	0.000734	CcSEcCtD
Trimethoprim—Stomatitis—Methotrexate—psoriasis	0.000153	0.000733	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000153	0.000731	CcSEcCtD
Trimethoprim—Immune system disorder—Prednisone—psoriasis	0.000152	0.00073	CcSEcCtD
Trimethoprim—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000152	0.00769	CbGpPWpGaD
Trimethoprim—Anaphylactic shock—Triamcinolone—psoriasis	0.000152	0.000726	CcSEcCtD
Trimethoprim—Vertigo—Betamethasone—psoriasis	0.000151	0.000725	CcSEcCtD
Trimethoprim—Vertigo—Dexamethasone—psoriasis	0.000151	0.000725	CcSEcCtD
Trimethoprim—Syncope—Betamethasone—psoriasis	0.000151	0.000724	CcSEcCtD
Trimethoprim—Syncope—Dexamethasone—psoriasis	0.000151	0.000724	CcSEcCtD
Trimethoprim—Constipation—Mycophenolate mofetil—psoriasis	0.000151	0.000724	CcSEcCtD
Trimethoprim—Haematuria—Methotrexate—psoriasis	0.00015	0.000717	CcSEcCtD
Trimethoprim—Feeling abnormal—Cyclosporine—psoriasis	0.000149	0.000715	CcSEcCtD
Trimethoprim—DHFR—Folate Metabolism—NFKB1—psoriasis	0.000149	0.00753	CbGpPWpGaD
Trimethoprim—Shock—Triamcinolone—psoriasis	0.000149	0.000715	CcSEcCtD
Trimethoprim—Insomnia—Prednisolone—psoriasis	0.000149	0.000714	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Methotrexate—psoriasis	0.000148	0.000711	CcSEcCtD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000148	0.00748	CbGpPWpGaD
Trimethoprim—Gastrointestinal pain—Cyclosporine—psoriasis	0.000148	0.00071	CcSEcCtD
Trimethoprim—Loss of consciousness—Betamethasone—psoriasis	0.000148	0.00071	CcSEcCtD
Trimethoprim—Loss of consciousness—Dexamethasone—psoriasis	0.000148	0.00071	CcSEcCtD
Trimethoprim—Dizziness—Mycophenolic acid—psoriasis	0.000148	0.000709	CcSEcCtD
Trimethoprim—Epistaxis—Methotrexate—psoriasis	0.000148	0.000709	CcSEcCtD
Trimethoprim—Mental disorder—Prednisone—psoriasis	0.000148	0.000708	CcSEcCtD
Trimethoprim—Erythema—Prednisone—psoriasis	0.000147	0.000703	CcSEcCtD
Trimethoprim—Malnutrition—Prednisone—psoriasis	0.000147	0.000703	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000147	0.000703	CcSEcCtD
Trimethoprim—Agranulocytosis—Methotrexate—psoriasis	0.000146	0.000702	CcSEcCtD
Trimethoprim—Convulsion—Betamethasone—psoriasis	0.000146	0.0007	CcSEcCtD
Trimethoprim—Convulsion—Dexamethasone—psoriasis	0.000146	0.0007	CcSEcCtD
Trimethoprim—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000146	0.000698	CcSEcCtD
Trimethoprim—Insomnia—Hydrocortisone—psoriasis	0.000146	0.000698	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000144	0.000692	CcSEcCtD
Trimethoprim—Urticaria—Cyclosporine—psoriasis	0.000144	0.000689	CcSEcCtD
Trimethoprim—Myalgia—Betamethasone—psoriasis	0.000143	0.000687	CcSEcCtD
Trimethoprim—Myalgia—Dexamethasone—psoriasis	0.000143	0.000687	CcSEcCtD
Trimethoprim—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000143	0.00724	CbGpPWpGaD
Trimethoprim—Body temperature increased—Cyclosporine—psoriasis	0.000143	0.000686	CcSEcCtD
Trimethoprim—Abdominal pain—Cyclosporine—psoriasis	0.000143	0.000686	CcSEcCtD
Trimethoprim—Anxiety—Dexamethasone—psoriasis	0.000143	0.000685	CcSEcCtD
Trimethoprim—Anxiety—Betamethasone—psoriasis	0.000143	0.000685	CcSEcCtD
Trimethoprim—Vomiting—Mycophenolic acid—psoriasis	0.000142	0.000682	CcSEcCtD
Trimethoprim—Dyspepsia—Hydrocortisone—psoriasis	0.000142	0.000679	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle, Mitotic—PTTG1—psoriasis	0.000141	0.00713	CbGpPWpGaD
Trimethoprim—Rash—Mycophenolic acid—psoriasis	0.000141	0.000676	CcSEcCtD
Trimethoprim—Dermatitis—Mycophenolic acid—psoriasis	0.000141	0.000676	CcSEcCtD
Trimethoprim—Urticaria—Mycophenolate mofetil—psoriasis	0.00014	0.000673	CcSEcCtD
Trimethoprim—Headache—Mycophenolic acid—psoriasis	0.00014	0.000672	CcSEcCtD
Trimethoprim—Decreased appetite—Hydrocortisone—psoriasis	0.00014	0.00067	CcSEcCtD
Trimethoprim—Abdominal pain—Mycophenolate mofetil—psoriasis	0.00014	0.000669	CcSEcCtD
Trimethoprim—Body temperature increased—Mycophenolate mofetil—psoriasis	0.00014	0.000669	CcSEcCtD
Trimethoprim—TYMS—Clobetasol propionate—Beclomethasone—psoriasis	0.00014	0.0194	CbGdCrCtD
Trimethoprim—TYMS—Clobetasol propionate—Fluocinonide—psoriasis	0.00014	0.0194	CbGdCrCtD
Trimethoprim—Urinary tract disorder—Methotrexate—psoriasis	0.000139	0.000667	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000139	0.000666	CcSEcCtD
Trimethoprim—Urethral disorder—Methotrexate—psoriasis	0.000138	0.000662	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000138	0.000662	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Fluocinonide—psoriasis	0.000138	0.0191	CbGdCrCtD
Trimethoprim—TYMS—Budesonide—Clobetasol propionate—psoriasis	0.000138	0.0191	CbGdCrCtD
Trimethoprim—Anaphylactic shock—Betamethasone—psoriasis	0.000138	0.000659	CcSEcCtD
Trimethoprim—Anaphylactic shock—Dexamethasone—psoriasis	0.000138	0.000659	CcSEcCtD
Trimethoprim—Insomnia—Triamcinolone—psoriasis	0.000137	0.000657	CcSEcCtD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—PCNA—psoriasis	0.000137	0.00691	CbGpPWpGaD
Trimethoprim—TYMS—Triamcinolone—Beclomethasone—psoriasis	0.000136	0.0189	CbGdCrCtD
Trimethoprim—TYMS—Triamcinolone—Fluocinonide—psoriasis	0.000136	0.0189	CbGdCrCtD
Trimethoprim—Feeling abnormal—Prednisolone—psoriasis	0.000136	0.000651	CcSEcCtD
Trimethoprim—TYMS—Clobetasol propionate—Fluocinolone Acetonide—psoriasis	0.000136	0.0188	CbGdCrCtD
Trimethoprim—Shock—Dexamethasone—psoriasis	0.000135	0.000648	CcSEcCtD
Trimethoprim—Shock—Betamethasone—psoriasis	0.000135	0.000648	CcSEcCtD
Trimethoprim—Dyspnoea—Triamcinolone—psoriasis	0.000135	0.000647	CcSEcCtD
Trimethoprim—Nervous system disorder—Betamethasone—psoriasis	0.000135	0.000646	CcSEcCtD
Trimethoprim—Nervous system disorder—Dexamethasone—psoriasis	0.000135	0.000646	CcSEcCtD
Trimethoprim—Agitation—Prednisone—psoriasis	0.000135	0.000646	CcSEcCtD
Trimethoprim—Thrombocytopenia—Dexamethasone—psoriasis	0.000135	0.000645	CcSEcCtD
Trimethoprim—Thrombocytopenia—Betamethasone—psoriasis	0.000135	0.000645	CcSEcCtD
Trimethoprim—Angioedema—Prednisone—psoriasis	0.000134	0.000643	CcSEcCtD
Trimethoprim—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000134	0.00677	CbGpPWpGaD
Trimethoprim—TYMS—Flunisolide—Fluocinolone Acetonide—psoriasis	0.000134	0.0186	CbGdCrCtD
Trimethoprim—Hypersensitivity—Cyclosporine—psoriasis	0.000133	0.000639	CcSEcCtD
Trimethoprim—Dyspepsia—Triamcinolone—psoriasis	0.000133	0.000639	CcSEcCtD
Trimethoprim—Erythema multiforme—Methotrexate—psoriasis	0.000133	0.000638	CcSEcCtD
Trimethoprim—Nausea—Mycophenolic acid—psoriasis	0.000133	0.000637	CcSEcCtD
Trimethoprim—TYMS—Fluticasone Propionate—Fluocinonide—psoriasis	0.000133	0.0184	CbGdCrCtD
Trimethoprim—TYMS—Fluticasone Propionate—Beclomethasone—psoriasis	0.000133	0.0184	CbGdCrCtD
Trimethoprim—Feeling abnormal—Hydrocortisone—psoriasis	0.000133	0.000636	CcSEcCtD
Trimethoprim—TYMS—Triamcinolone—Fluocinolone Acetonide—psoriasis	0.000132	0.0184	CbGdCrCtD
Trimethoprim—Vertigo—Prednisone—psoriasis	0.000132	0.000632	CcSEcCtD
Trimethoprim—Eye disorder—Methotrexate—psoriasis	0.000132	0.000631	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000132	0.000631	CcSEcCtD
Trimethoprim—Syncope—Prednisone—psoriasis	0.000132	0.000631	CcSEcCtD
Trimethoprim—Tinnitus—Methotrexate—psoriasis	0.000131	0.000629	CcSEcCtD
Trimethoprim—Anorexia—Betamethasone—psoriasis	0.000131	0.000628	CcSEcCtD
Trimethoprim—Anorexia—Dexamethasone—psoriasis	0.000131	0.000628	CcSEcCtD
Trimethoprim—Urticaria—Prednisolone—psoriasis	0.000131	0.000627	CcSEcCtD
Trimethoprim—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.00013	0.000624	CcSEcCtD
Trimethoprim—TYMS—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.000129	0.0179	CbGdCrCtD
Trimethoprim—Loss of consciousness—Prednisone—psoriasis	0.000129	0.000618	CcSEcCtD
Trimethoprim—Pruritus—Cyclosporine—psoriasis	0.000128	0.000614	CcSEcCtD
Trimethoprim—Urticaria—Hydrocortisone—psoriasis	0.000128	0.000613	CcSEcCtD
Trimethoprim—Immune system disorder—Methotrexate—psoriasis	0.000127	0.00061	CcSEcCtD
Trimethoprim—Abdominal pain—Hydrocortisone—psoriasis	0.000127	0.00061	CcSEcCtD
Trimethoprim—Body temperature increased—Hydrocortisone—psoriasis	0.000127	0.00061	CcSEcCtD
Trimethoprim—Convulsion—Prednisone—psoriasis	0.000127	0.000609	CcSEcCtD
Trimethoprim—Mediastinal disorder—Methotrexate—psoriasis	0.000127	0.000608	CcSEcCtD
Trimethoprim—DHFR—Cell Cycle—PTTG1—psoriasis	0.000126	0.00637	CbGpPWpGaD
Trimethoprim—TYMS—Diflorasone—Beclomethasone—psoriasis	0.000126	0.0174	CbGdCrCtD
Trimethoprim—TYMS—Diflorasone—Fluocinonide—psoriasis	0.000126	0.0174	CbGdCrCtD
Trimethoprim—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000126	0.00634	CbGpPWpGaD
Trimethoprim—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000125	0.0006	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000125	0.0006	CcSEcCtD
Trimethoprim—Pruritus—Mycophenolate mofetil—psoriasis	0.000125	0.000599	CcSEcCtD
Trimethoprim—Arthralgia—Prednisone—psoriasis	0.000125	0.000599	CcSEcCtD
Trimethoprim—Myalgia—Prednisone—psoriasis	0.000125	0.000599	CcSEcCtD
Trimethoprim—Feeling abnormal—Triamcinolone—psoriasis	0.000125	0.000598	CcSEcCtD
Trimethoprim—Anxiety—Prednisone—psoriasis	0.000124	0.000597	CcSEcCtD
Trimethoprim—Insomnia—Betamethasone—psoriasis	0.000124	0.000596	CcSEcCtD
Trimethoprim—Insomnia—Dexamethasone—psoriasis	0.000124	0.000596	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000124	0.000595	CcSEcCtD
Trimethoprim—Diarrhoea—Cyclosporine—psoriasis	0.000124	0.000594	CcSEcCtD
Trimethoprim—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000124	0.00626	CbGpPWpGaD
Trimethoprim—Mental disorder—Methotrexate—psoriasis	0.000123	0.000591	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle, Mitotic—PTTG1—psoriasis	0.000123	0.00622	CbGpPWpGaD
Trimethoprim—Erythema—Methotrexate—psoriasis	0.000123	0.000588	CcSEcCtD
Trimethoprim—Malnutrition—Methotrexate—psoriasis	0.000123	0.000588	CcSEcCtD
Trimethoprim—TYMS—Diflorasone—Fluocinolone Acetonide—psoriasis	0.000122	0.0169	CbGdCrCtD
Trimethoprim—Hypersensitivity—Prednisolone—psoriasis	0.000121	0.000582	CcSEcCtD
Trimethoprim—Dyspepsia—Dexamethasone—psoriasis	0.000121	0.00058	CcSEcCtD
Trimethoprim—Dyspepsia—Betamethasone—psoriasis	0.000121	0.00058	CcSEcCtD
Trimethoprim—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000121	0.000579	CcSEcCtD
Trimethoprim—Urticaria—Triamcinolone—psoriasis	0.00012	0.000577	CcSEcCtD
Trimethoprim—Body temperature increased—Triamcinolone—psoriasis	0.00012	0.000574	CcSEcCtD
Trimethoprim—Dizziness—Cyclosporine—psoriasis	0.00012	0.000574	CcSEcCtD
Trimethoprim—Anaphylactic shock—Prednisone—psoriasis	0.00012	0.000574	CcSEcCtD
Trimethoprim—Decreased appetite—Betamethasone—psoriasis	0.00012	0.000573	CcSEcCtD
Trimethoprim—Decreased appetite—Dexamethasone—psoriasis	0.00012	0.000573	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Betamethasone—psoriasis	0.000119	0.000569	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000119	0.000569	CcSEcCtD
Trimethoprim—Hypersensitivity—Hydrocortisone—psoriasis	0.000119	0.000568	CcSEcCtD
Trimethoprim—Shock—Prednisone—psoriasis	0.000118	0.000565	CcSEcCtD
Trimethoprim—Nervous system disorder—Prednisone—psoriasis	0.000117	0.000563	CcSEcCtD
Trimethoprim—Dizziness—Mycophenolate mofetil—psoriasis	0.000117	0.00056	CcSEcCtD
Trimethoprim—Skin disorder—Prednisone—psoriasis	0.000116	0.000557	CcSEcCtD
Trimethoprim—DHFR—Folate Metabolism—TNF—psoriasis	0.000116	0.00586	CbGpPWpGaD
Trimethoprim—Vomiting—Cyclosporine—psoriasis	0.000115	0.000552	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000114	0.00577	CbGpPWpGaD
Trimethoprim—Rash—Cyclosporine—psoriasis	0.000114	0.000547	CcSEcCtD
Trimethoprim—Anorexia—Prednisone—psoriasis	0.000114	0.000547	CcSEcCtD
Trimethoprim—Dermatitis—Cyclosporine—psoriasis	0.000114	0.000547	CcSEcCtD
Trimethoprim—Pruritus—Hydrocortisone—psoriasis	0.000114	0.000546	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—IL13—psoriasis	0.000114	0.00574	CbGpPWpGaD
Trimethoprim—Headache—Cyclosporine—psoriasis	0.000113	0.000544	CcSEcCtD
Trimethoprim—Feeling abnormal—Dexamethasone—psoriasis	0.000113	0.000543	CcSEcCtD
Trimethoprim—Feeling abnormal—Betamethasone—psoriasis	0.000113	0.000543	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Betamethasone—psoriasis	0.000112	0.000539	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Dexamethasone—psoriasis	0.000112	0.000539	CcSEcCtD
Trimethoprim—Vomiting—Mycophenolate mofetil—psoriasis	0.000112	0.000538	CcSEcCtD
Trimethoprim—Hypersensitivity—Triamcinolone—psoriasis	0.000112	0.000535	CcSEcCtD
Trimethoprim—Rash—Mycophenolate mofetil—psoriasis	0.000111	0.000534	CcSEcCtD
Trimethoprim—Dermatitis—Mycophenolate mofetil—psoriasis	0.000111	0.000533	CcSEcCtD
Trimethoprim—Headache—Mycophenolate mofetil—psoriasis	0.000111	0.00053	CcSEcCtD
Trimethoprim—Vertigo—Methotrexate—psoriasis	0.00011	0.000528	CcSEcCtD
Trimethoprim—TYMS—Cell Cycle—PTTG1—psoriasis	0.00011	0.00556	CbGpPWpGaD
Trimethoprim—TYMS—Budesonide—Beclomethasone—psoriasis	0.00011	0.0153	CbGdCrCtD
Trimethoprim—TYMS—Budesonide—Fluocinonide—psoriasis	0.00011	0.0153	CbGdCrCtD
Trimethoprim—Diarrhoea—Hydrocortisone—psoriasis	0.00011	0.000528	CcSEcCtD
Trimethoprim—Leukopenia—Methotrexate—psoriasis	0.00011	0.000526	CcSEcCtD
Trimethoprim—Urticaria—Betamethasone—psoriasis	0.000109	0.000524	CcSEcCtD
Trimethoprim—Urticaria—Dexamethasone—psoriasis	0.000109	0.000524	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Prednisone—psoriasis	0.000109	0.000523	CcSEcCtD
Trimethoprim—Dizziness—Prednisolone—psoriasis	0.000109	0.000522	CcSEcCtD
Trimethoprim—Body temperature increased—Betamethasone—psoriasis	0.000109	0.000521	CcSEcCtD
Trimethoprim—Body temperature increased—Dexamethasone—psoriasis	0.000109	0.000521	CcSEcCtD
Trimethoprim—Abdominal pain—Dexamethasone—psoriasis	0.000109	0.000521	CcSEcCtD
Trimethoprim—Abdominal pain—Betamethasone—psoriasis	0.000109	0.000521	CcSEcCtD
Trimethoprim—Insomnia—Prednisone—psoriasis	0.000108	0.000519	CcSEcCtD
Trimethoprim—Nausea—Cyclosporine—psoriasis	0.000108	0.000516	CcSEcCtD
Trimethoprim—Pruritus—Triamcinolone—psoriasis	0.000107	0.000514	CcSEcCtD
Trimethoprim—TYMS—Budesonide—Fluocinolone Acetonide—psoriasis	0.000107	0.0148	CbGdCrCtD
Trimethoprim—Cough—Methotrexate—psoriasis	0.000107	0.000513	CcSEcCtD
Trimethoprim—Dizziness—Hydrocortisone—psoriasis	0.000106	0.00051	CcSEcCtD
Trimethoprim—Convulsion—Methotrexate—psoriasis	0.000106	0.000509	CcSEcCtD
Trimethoprim—Dyspepsia—Prednisone—psoriasis	0.000105	0.000505	CcSEcCtD
Trimethoprim—Nausea—Mycophenolate mofetil—psoriasis	0.000105	0.000503	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000105	0.00528	CbGpPWpGaD
Trimethoprim—Arthralgia—Methotrexate—psoriasis	0.000104	0.0005	CcSEcCtD
Trimethoprim—Myalgia—Methotrexate—psoriasis	0.000104	0.0005	CcSEcCtD
Trimethoprim—Decreased appetite—Prednisone—psoriasis	0.000104	0.000499	CcSEcCtD
Trimethoprim—Rash—Prednisolone—psoriasis	0.000104	0.000498	CcSEcCtD
Trimethoprim—Dermatitis—Prednisolone—psoriasis	0.000104	0.000497	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.000104	0.00524	CbGpPWpGaD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000104	0.000497	CcSEcCtD
Trimethoprim—Headache—Prednisolone—psoriasis	0.000103	0.000495	CcSEcCtD
Trimethoprim—Constipation—Prednisone—psoriasis	0.000102	0.000491	CcSEcCtD
Trimethoprim—Vomiting—Hydrocortisone—psoriasis	0.000102	0.00049	CcSEcCtD
Trimethoprim—DHFR—Folate Metabolism—TP53—psoriasis	0.000102	0.00516	CbGpPWpGaD
Trimethoprim—Rash—Hydrocortisone—psoriasis	0.000101	0.000486	CcSEcCtD
Trimethoprim—Dermatitis—Hydrocortisone—psoriasis	0.000101	0.000486	CcSEcCtD
Trimethoprim—Confusional state—Methotrexate—psoriasis	0.000101	0.000484	CcSEcCtD
Trimethoprim—Headache—Hydrocortisone—psoriasis	0.000101	0.000483	CcSEcCtD
Trimethoprim—DHFR—Metabolism—NDUFA5—psoriasis	0.0001	0.00507	CbGpPWpGaD
Trimethoprim—Dizziness—Triamcinolone—psoriasis	0.0001	0.00048	CcSEcCtD
Trimethoprim—Anaphylactic shock—Methotrexate—psoriasis	0.0001	0.00048	CcSEcCtD
Trimethoprim—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.0001	0.00505	CbGpPWpGaD
Trimethoprim—Feeling abnormal—Prednisone—psoriasis	9.87e-05	0.000473	CcSEcCtD
Trimethoprim—Nervous system disorder—Methotrexate—psoriasis	9.82e-05	0.00047	CcSEcCtD
Trimethoprim—Thrombocytopenia—Methotrexate—psoriasis	9.8e-05	0.00047	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Prednisone—psoriasis	9.79e-05	0.000469	CcSEcCtD
Trimethoprim—Nausea—Prednisolone—psoriasis	9.79e-05	0.000469	CcSEcCtD
Trimethoprim—Pruritus—Betamethasone—psoriasis	9.73e-05	0.000466	CcSEcCtD
Trimethoprim—Pruritus—Dexamethasone—psoriasis	9.73e-05	0.000466	CcSEcCtD
Trimethoprim—Skin disorder—Methotrexate—psoriasis	9.72e-05	0.000466	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—IL12B—psoriasis	9.72e-05	0.00491	CbGpPWpGaD
Trimethoprim—Vomiting—Triamcinolone—psoriasis	9.64e-05	0.000462	CcSEcCtD
Trimethoprim—Nausea—Hydrocortisone—psoriasis	9.56e-05	0.000458	CcSEcCtD
Trimethoprim—Rash—Triamcinolone—psoriasis	9.56e-05	0.000458	CcSEcCtD
Trimethoprim—Dermatitis—Triamcinolone—psoriasis	9.55e-05	0.000457	CcSEcCtD
Trimethoprim—Anorexia—Methotrexate—psoriasis	9.54e-05	0.000457	CcSEcCtD
Trimethoprim—Urticaria—Prednisone—psoriasis	9.51e-05	0.000456	CcSEcCtD
Trimethoprim—Headache—Triamcinolone—psoriasis	9.49e-05	0.000455	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—HLA-E—psoriasis	9.49e-05	0.00479	CbGpPWpGaD
Trimethoprim—Abdominal pain—Prednisone—psoriasis	9.47e-05	0.000454	CcSEcCtD
Trimethoprim—Body temperature increased—Prednisone—psoriasis	9.47e-05	0.000454	CcSEcCtD
Trimethoprim—Diarrhoea—Betamethasone—psoriasis	9.41e-05	0.000451	CcSEcCtD
Trimethoprim—Diarrhoea—Dexamethasone—psoriasis	9.41e-05	0.000451	CcSEcCtD
Trimethoprim—DHFR—Folate Metabolism—IL6—psoriasis	9.36e-05	0.00473	CbGpPWpGaD
Trimethoprim—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.34e-05	0.00472	CbGpPWpGaD
Trimethoprim—Musculoskeletal discomfort—Methotrexate—psoriasis	9.12e-05	0.000437	CcSEcCtD
Trimethoprim—Dizziness—Dexamethasone—psoriasis	9.09e-05	0.000436	CcSEcCtD
Trimethoprim—Dizziness—Betamethasone—psoriasis	9.09e-05	0.000436	CcSEcCtD
Trimethoprim—Insomnia—Methotrexate—psoriasis	9.05e-05	0.000434	CcSEcCtD
Trimethoprim—Nausea—Triamcinolone—psoriasis	9e-05	0.000431	CcSEcCtD
Trimethoprim—TYMS—Circadian rythm related genes—LEP—psoriasis	8.98e-05	0.00453	CbGpPWpGaD
Trimethoprim—Dyspnoea—Methotrexate—psoriasis	8.92e-05	0.000428	CcSEcCtD
Trimethoprim—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.84e-05	0.00446	CbGpPWpGaD
Trimethoprim—Hypersensitivity—Prednisone—psoriasis	8.82e-05	0.000423	CcSEcCtD
Trimethoprim—Dyspepsia—Methotrexate—psoriasis	8.81e-05	0.000422	CcSEcCtD
Trimethoprim—TYMS—Metabolism—NDUFA5—psoriasis	8.77e-05	0.00443	CbGpPWpGaD
Trimethoprim—Vomiting—Dexamethasone—psoriasis	8.74e-05	0.000419	CcSEcCtD
Trimethoprim—Vomiting—Betamethasone—psoriasis	8.74e-05	0.000419	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	8.72e-05	0.0044	CbGpPWpGaD
Trimethoprim—Decreased appetite—Methotrexate—psoriasis	8.7e-05	0.000417	CcSEcCtD
Trimethoprim—Rash—Dexamethasone—psoriasis	8.67e-05	0.000415	CcSEcCtD
Trimethoprim—Rash—Betamethasone—psoriasis	8.67e-05	0.000415	CcSEcCtD
Trimethoprim—Dermatitis—Betamethasone—psoriasis	8.66e-05	0.000415	CcSEcCtD
Trimethoprim—Dermatitis—Dexamethasone—psoriasis	8.66e-05	0.000415	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Methotrexate—psoriasis	8.64e-05	0.000414	CcSEcCtD
Trimethoprim—Headache—Dexamethasone—psoriasis	8.62e-05	0.000413	CcSEcCtD
Trimethoprim—Headache—Betamethasone—psoriasis	8.62e-05	0.000413	CcSEcCtD
Trimethoprim—DHFR—Metabolism—CYP2S1—psoriasis	8.54e-05	0.00431	CbGpPWpGaD
Trimethoprim—Pruritus—Prednisone—psoriasis	8.47e-05	0.000406	CcSEcCtD
Trimethoprim—TYMS—Circadian rythm related genes—NOS2—psoriasis	8.37e-05	0.00422	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—CYP2S1—psoriasis	8.28e-05	0.00418	CbGpPWpGaD
Trimethoprim—Feeling abnormal—Methotrexate—psoriasis	8.25e-05	0.000395	CcSEcCtD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—TP53—psoriasis	8.2e-05	0.00414	CbGpPWpGaD
Trimethoprim—Diarrhoea—Prednisone—psoriasis	8.19e-05	0.000393	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Methotrexate—psoriasis	8.18e-05	0.000392	CcSEcCtD
Trimethoprim—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	8.17e-05	0.00413	CbGpPWpGaD
Trimethoprim—Nausea—Dexamethasone—psoriasis	8.17e-05	0.000391	CcSEcCtD
Trimethoprim—Nausea—Betamethasone—psoriasis	8.17e-05	0.000391	CcSEcCtD
Trimethoprim—Urticaria—Methotrexate—psoriasis	7.95e-05	0.000381	CcSEcCtD
Trimethoprim—Dizziness—Prednisone—psoriasis	7.92e-05	0.000379	CcSEcCtD
Trimethoprim—Body temperature increased—Methotrexate—psoriasis	7.91e-05	0.000379	CcSEcCtD
Trimethoprim—Abdominal pain—Methotrexate—psoriasis	7.91e-05	0.000379	CcSEcCtD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.85e-05	0.00397	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—PPARG—psoriasis	7.82e-05	0.00395	CbGpPWpGaD
Trimethoprim—Vomiting—Prednisone—psoriasis	7.61e-05	0.000365	CcSEcCtD
Trimethoprim—Rash—Prednisone—psoriasis	7.55e-05	0.000362	CcSEcCtD
Trimethoprim—Dermatitis—Prednisone—psoriasis	7.54e-05	0.000362	CcSEcCtD
Trimethoprim—Headache—Prednisone—psoriasis	7.5e-05	0.00036	CcSEcCtD
Trimethoprim—TYMS—Metabolism—CYP2S1—psoriasis	7.45e-05	0.00376	CbGpPWpGaD
Trimethoprim—Hypersensitivity—Methotrexate—psoriasis	7.37e-05	0.000353	CcSEcCtD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—TP53—psoriasis	7.16e-05	0.00361	CbGpPWpGaD
Trimethoprim—CYP3A4—Tryptophan metabolism—CAT—psoriasis	7.15e-05	0.00361	CbGpPWpGaD
Trimethoprim—Nausea—Prednisone—psoriasis	7.11e-05	0.000341	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—IL10—psoriasis	7.11e-05	0.00359	CbGpPWpGaD
Trimethoprim—Pruritus—Methotrexate—psoriasis	7.08e-05	0.000339	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—IL4—psoriasis	6.91e-05	0.00349	CbGpPWpGaD
Trimethoprim—Diarrhoea—Methotrexate—psoriasis	6.85e-05	0.000328	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.76e-05	0.00341	CbGpPWpGaD
Trimethoprim—TYMS—Flunisolide—Hydrocortisone—psoriasis	6.76e-05	0.00938	CbGdCrCtD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.75e-05	0.00341	CbGpPWpGaD
Trimethoprim—TYMS—Triamcinolone—Hydrocortisone—psoriasis	6.69e-05	0.00928	CbGdCrCtD
Trimethoprim—Dizziness—Methotrexate—psoriasis	6.62e-05	0.000317	CcSEcCtD
Trimethoprim—Vomiting—Methotrexate—psoriasis	6.36e-05	0.000305	CcSEcCtD
Trimethoprim—TYMS—Clobetasol propionate—Dexamethasone—psoriasis	6.36e-05	0.00882	CbGdCrCtD
Trimethoprim—TYMS—Clobetasol propionate—Betamethasone—psoriasis	6.36e-05	0.00882	CbGdCrCtD
Trimethoprim—Rash—Methotrexate—psoriasis	6.31e-05	0.000302	CcSEcCtD
Trimethoprim—Dermatitis—Methotrexate—psoriasis	6.3e-05	0.000302	CcSEcCtD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	6.29e-05	0.00318	CbGpPWpGaD
Trimethoprim—TYMS—Flunisolide—Dexamethasone—psoriasis	6.28e-05	0.00871	CbGdCrCtD
Trimethoprim—TYMS—Flunisolide—Betamethasone—psoriasis	6.28e-05	0.00871	CbGdCrCtD
Trimethoprim—Headache—Methotrexate—psoriasis	6.27e-05	0.0003	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—HLA-A—psoriasis	6.26e-05	0.00316	CbGpPWpGaD
Trimethoprim—TYMS—Clobetasol propionate—Triamcinolone—psoriasis	6.21e-05	0.00862	CbGdCrCtD
Trimethoprim—TYMS—Triamcinolone—Dexamethasone—psoriasis	6.21e-05	0.00862	CbGdCrCtD
Trimethoprim—TYMS—Triamcinolone—Betamethasone—psoriasis	6.21e-05	0.00862	CbGdCrCtD
Trimethoprim—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.16e-05	0.00311	CbGpPWpGaD
Trimethoprim—TYMS—Flunisolide—Triamcinolone—psoriasis	6.13e-05	0.00851	CbGdCrCtD
Trimethoprim—TYMS—Fluticasone Propionate—Dexamethasone—psoriasis	6.06e-05	0.0084	CbGdCrCtD
Trimethoprim—TYMS—Fluticasone Propionate—Betamethasone—psoriasis	6.06e-05	0.0084	CbGdCrCtD
Trimethoprim—Nausea—Methotrexate—psoriasis	5.95e-05	0.000285	CcSEcCtD
Trimethoprim—TYMS—Fluticasone Propionate—Triamcinolone—psoriasis	5.92e-05	0.00821	CbGdCrCtD
Trimethoprim—TYMS—Clobetasol propionate—Prednisone—psoriasis	5.9e-05	0.00818	CbGdCrCtD
Trimethoprim—TYMS—Flunisolide—Prednisone—psoriasis	5.82e-05	0.00807	CbGdCrCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	5.78e-05	0.00292	CbGpPWpGaD
Trimethoprim—TYMS—Triamcinolone—Prednisone—psoriasis	5.76e-05	0.00799	CbGdCrCtD
Trimethoprim—TYMS—Clobetasol propionate—Prednisolone—psoriasis	5.76e-05	0.00798	CbGdCrCtD
Trimethoprim—DHFR—Cell Cycle, Mitotic—PCNA—psoriasis	5.76e-05	0.00291	CbGpPWpGaD
Trimethoprim—TYMS—Diflorasone—Dexamethasone—psoriasis	5.73e-05	0.00794	CbGdCrCtD
Trimethoprim—TYMS—Diflorasone—Betamethasone—psoriasis	5.73e-05	0.00794	CbGdCrCtD
Trimethoprim—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.72e-05	0.00289	CbGpPWpGaD
Trimethoprim—TYMS—Flunisolide—Prednisolone—psoriasis	5.68e-05	0.00788	CbGdCrCtD
Trimethoprim—TYMS—Triamcinolone—Prednisolone—psoriasis	5.62e-05	0.0078	CbGdCrCtD
Trimethoprim—TYMS—Diflorasone—Triamcinolone—psoriasis	5.6e-05	0.00776	CbGdCrCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	5.56e-05	0.00281	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—JUN—psoriasis	5.55e-05	0.0028	CbGpPWpGaD
Trimethoprim—TYMS—Budesonide—Hydrocortisone—psoriasis	5.41e-05	0.0075	CbGdCrCtD
Trimethoprim—TYMS—Diflorasone—Prednisone—psoriasis	5.31e-05	0.00737	CbGdCrCtD
Trimethoprim—TYMS—Diflorasone—Prednisolone—psoriasis	5.18e-05	0.00719	CbGdCrCtD
Trimethoprim—TYMS—Danazol—Hydrocortisone—psoriasis	5.18e-05	0.00719	CbGdCrCtD
Trimethoprim—DHFR—Cell Cycle—PCNA—psoriasis	5.15e-05	0.0026	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	5.05e-05	0.00255	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—PCNA—psoriasis	5.02e-05	0.00254	CbGpPWpGaD
Trimethoprim—TYMS—Budesonide—Dexamethasone—psoriasis	5.02e-05	0.00696	CbGdCrCtD
Trimethoprim—TYMS—Budesonide—Betamethasone—psoriasis	5.02e-05	0.00696	CbGdCrCtD
Trimethoprim—TYMS—Budesonide—Triamcinolone—psoriasis	4.91e-05	0.0068	CbGdCrCtD
Trimethoprim—TYMS—Budesonide—Prednisone—psoriasis	4.66e-05	0.00646	CbGdCrCtD
Trimethoprim—TYMS—Budesonide—Prednisolone—psoriasis	4.54e-05	0.0063	CbGdCrCtD
Trimethoprim—TYMS—Cell Cycle—PCNA—psoriasis	4.49e-05	0.00227	CbGpPWpGaD
Trimethoprim—TYMS—Danazol—Prednisone—psoriasis	4.46e-05	0.00619	CbGdCrCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.33e-05	0.00218	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—IFNG—psoriasis	4.18e-05	0.00211	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	4.17e-05	0.00211	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CARM1—psoriasis	4.17e-05	0.00211	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.89e-05	0.00196	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.81e-05	0.00193	CbGpPWpGaD
Trimethoprim—TYMS—Levonorgestrel—Hydrocortisone—psoriasis	3.71e-05	0.00515	CbGdCrCtD
Trimethoprim—TYMS—Circadian rythm related genes—TP53—psoriasis	3.66e-05	0.00185	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.64e-05	0.00184	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CARM1—psoriasis	3.64e-05	0.00184	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—IL6—psoriasis	3.35e-05	0.00169	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.2e-05	0.00162	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—VEGFA—psoriasis	3.16e-05	0.00159	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NDUFA5—psoriasis	3.1e-05	0.00157	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.89e-05	0.00146	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—TNF—psoriasis	2.71e-05	0.00137	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NDUFA5—psoriasis	2.7e-05	0.00137	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.69e-05	0.00136	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP2S1—psoriasis	2.64e-05	0.00133	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CAT—psoriasis	2.57e-05	0.0013	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HLA-A—psoriasis	2.55e-05	0.00129	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NDUFA5—psoriasis	2.53e-05	0.00128	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.51e-05	0.00127	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.4e-05	0.00121	CbGpPWpGaD
Trimethoprim—DHFR—Disease—APOE—psoriasis	2.38e-05	0.0012	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.36e-05	0.00119	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP2S1—psoriasis	2.3e-05	0.00116	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CAT—psoriasis	2.24e-05	0.00113	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NOS2—psoriasis	2.22e-05	0.00112	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP2S1—psoriasis	2.15e-05	0.00108	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—APOE—psoriasis	1.99e-05	0.00101	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TP53—psoriasis	1.89e-05	0.000955	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TYK2—psoriasis	1.82e-05	0.000917	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.78e-05	0.0009	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—APOE—psoriasis	1.74e-05	0.000878	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PPARG—psoriasis	1.74e-05	0.000877	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.72e-05	0.000867	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NDUFA5—psoriasis	1.67e-05	0.000841	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TP53—psoriasis	1.65e-05	0.000834	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CD4—psoriasis	1.64e-05	0.00083	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.56e-05	0.000786	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PPARG—psoriasis	1.52e-05	0.000765	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP2S1—psoriasis	1.42e-05	0.000715	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.38e-05	0.000698	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.34e-05	0.000674	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CARM1—psoriasis	1.29e-05	0.000651	CbGpPWpGaD
Trimethoprim—DHFR—Disease—STAT3—psoriasis	1.27e-05	0.000642	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.2e-05	0.000608	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.18e-05	0.000594	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.13e-05	0.000568	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CARM1—psoriasis	1.12e-05	0.000567	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CARM1—psoriasis	1.05e-05	0.00053	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.81e-06	0.000495	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IL6—psoriasis	8.89e-06	0.000449	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CAT—psoriasis	7.93e-06	0.0004	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CARM1—psoriasis	6.92e-06	0.000349	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CAT—psoriasis	6.91e-06	0.000349	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CAT—psoriasis	6.45e-06	0.000326	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—APOE—psoriasis	6.16e-06	0.000311	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—APOE—psoriasis	5.37e-06	0.000271	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PPARG—psoriasis	5.37e-06	0.000271	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—APOE—psoriasis	5.01e-06	0.000253	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PPARG—psoriasis	4.68e-06	0.000236	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PPARG—psoriasis	4.37e-06	0.000221	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CAT—psoriasis	4.26e-06	0.000215	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—APOE—psoriasis	3.31e-06	0.000167	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PPARG—psoriasis	2.88e-06	0.000145	CbGpPWpGaD
